Prognostic factors for patients with diffuse large B cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the positron emission tomography era-Reference-Cited by-同舟云学术

Prognostic factors for patients with diffuse large B cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the positron emission tomography era

Published:2012-12-29 Issue:5 Volume:160 Page:608-617
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Armand Philippe¹,Welch Sarah²,Kim Haesook T.³,LaCasce Ann S.¹,Jacobsen Eric D.¹,Davids Matthew S.¹,Jacobson Caron¹,Fisher David C.¹,Brown Jennifer R.¹,Coughlin Erin⁴,Freedman Arnold S.¹,Chen Yi-Bin⁴

Affiliation:

1. Department of Medical Oncology; Dana-Farber Cancer Institute; Boston; MA; USA

2. Division of Graduate Medical Sciences; Boston University School of Medicine; Boston; MA; USA

3. Department of Biostatistics and Computational Biology; Dana-Farber Cancer Institute; Boston; MA; USA

4. Bone Marrow Transplant Unit, Division of Hematology/Oncology; Massachusetts General Hospital; Boston; MA; USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12176/fullpdf

Reference30 articles.

1. Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell transplantation;Alousi;British Journal of Haematology,2008

2. Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma;Andreadis;Bone Marrow Transplantation,2005

3. High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era;Ban-Hoefen;Leukaemia & Lymphoma,2011

4. Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphoma;Buadi;Bone Marrow Transplantation,2006

5. High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: the Stanford University experience;Cao;Biology of Blood and Marrow Transplantation,2001

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early failure is still a poor prognostic factor in patients with relapsed or refractory large B-cell lymphoma in the era of CAR T-cell therapy;Journal of Clinical and Experimental Hematopathology;2024

2. A paradox of choice: Sequencing therapy in relapsed/refractory diffuse large B-cell lymphoma;Blood Reviews;2024-01

3. Use of locally produced anti-CD19 CAR-T cells in the treatment of relapsed/refractory B-cell lymphomas in adults;Oncohematology;2023-09-11

4. ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Diffuse Large B Cell Lymphoma;Transplantation and Cellular Therapy;2023-09

5. CD19/CD22 chimeric antigen receptor (CAR) T-cell cocktail therapy following autologous transplantation in patients with relapsed/refractory diffuse large B-cell lymphoma on 18F-FDG PET/CT: a case description;Quantitative Imaging in Medicine and Surgery;2023-07